Linderoth B, Herregodts P, Meyerson B A
Department of Neurosurgery, Karolinska Hospital, Stockholm, Sweden.
Neurosurgery. 1994 Oct;35(4):711-9. doi: 10.1227/00006123-199410000-00018.
Electric spinal cord stimulation (SCS) is widely used as a treatment modality for ischemic pain in peripheral arterial insufficiency. The background for the therapeutic effect may be a temporary inhibition of sympathetically maintained peripheral vasoconstriction. In this series of experiments, the involvement of different types of cholinergic and adrenergic receptor subclasses in the vasodilatory effect was explored in anesthetized rats. The microcirculation in hindlimb skin and hamstring muscle was studied by the laser Doppler technique. The ganglionic blocker hexamethonium as well as the nicotinic receptor antagonist chlorisondamine abolished the effect in both vascular beds, whereas the muscarinic receptor antagonists pirenzepine and atropine were ineffective. Among the adrenergic receptor active compounds, phentolamine, prazosine (an alpha 1-receptor antagonist), and clonidine in high doses suppressed the SCS-induced vasodilation. Yohimbine (an alpha 2-receptor antagonist) did not alter the effect. The beta-adrenergic compounds had a differential effect on muscle and skin perfusion. Atenolol, a beta 1-receptor antagonist, inhibited SCS-induced vasodilation only in the skin, whereas the beta 2-receptor antagonist butoxamine selectively depressed the muscle response. The vasodilatory effect of SCS in the animal model used here seems to a large extent to be mediated by an inhibitory effect on peripheral vasoconstriction maintained via efferent sympathetic activity involving nicotinic transmission in the ganglia and the postganglionic alpha 1-adrenoreceptors. The involvement of beta-receptors seems to be different in skin and muscle, beta 1 being more important for the changes in the skin and beta 2 being more important for those in muscle. The high-intensity antidromic response, earlier believed to explain how SCS exerted its vasodilatory effect, was resistant to cholinergic and adrenergic manipulations and seems to depend on entirely different mechanisms.
电脊髓刺激(SCS)被广泛用作治疗外周动脉供血不足所致缺血性疼痛的一种治疗方式。其治疗效果的背景可能是对交感神经维持的外周血管收缩的暂时抑制。在这一系列实验中,在麻醉大鼠中探究了不同类型的胆碱能和肾上腺素能受体亚类在血管舒张效应中的作用。通过激光多普勒技术研究后肢皮肤和腘绳肌的微循环。神经节阻滞剂六甲铵以及烟碱受体拮抗剂氯筒箭毒碱消除了两个血管床中的效应,而毒蕈碱受体拮抗剂哌仑西平和阿托品则无效。在肾上腺素能受体活性化合物中,酚妥拉明、哌唑嗪(一种α1受体拮抗剂)和高剂量的可乐定抑制了SCS诱导的血管舒张。育亨宾(一种α2受体拮抗剂)未改变该效应。β肾上腺素能化合物对肌肉和皮肤灌注有不同的作用。β1受体拮抗剂阿替洛尔仅抑制SCS诱导的皮肤血管舒张,而β2受体拮抗剂布托沙明选择性地抑制肌肉反应。在此处使用的动物模型中,SCS的血管舒张效应在很大程度上似乎是由对通过神经节中烟碱传递和节后α1肾上腺素能受体维持的外周血管收缩的抑制作用介导的。β受体在皮肤和肌肉中的作用似乎不同,β1对皮肤变化更重要,而β2对肌肉变化更重要。高强度逆向反应,早期认为可解释SCS如何发挥其血管舒张作用,对胆碱能和肾上腺素能操作有抗性,似乎依赖于完全不同的机制。